What if a longevity breakthrough upends pensions and insurers?
A longevity breakthrough is a slow-burn duration repricing, not a tradable shock day-one: the modeled move is a faint risk-on tick (SOL up, spreads tighter). The real trade is liability-side - longer payout tails hit defined-benefit pensions and annuity writers, while life insurers with longevity exposure re-rate. No clean market analogue exists; it rhymes more with a demographic regime shift than any single event. Skeptic: clinical-to-population lag is a decade, so this is a thematic allocation (insurers, REITs, healthcare capacity), not a near-term position.
Every number ships with its receipt — the odds, the range, the precedents, and a public grade at Reality Check. The statistical machinery that produces it is proprietary.
The butterfly cascade
How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.
Resolution timeline — how this probability is moving
Our model's odds (electric blue) over time vs the market's (Polymarket, amber), from the past toward the 3–10 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. Loading the probability audit trail…
What it would mean
If this plays out, it is a mixed shock. A breakthrough longevity therapy extends healthy lifespan, repricing pensions and insurers. The trigger decomposes into signed root‑shocks — Risk appetite ▲ · Growth surprise ▲ — which propagate through our causal graph to the markets below.